


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+5.83%
+2.36%
-13.03%
-17.75%
+2.35%
ASTH
Astrana Health Inc.
$23.05
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
Chart
$31.21 (-26.15%)
$30.82 (-25.21%)
$31.21 (-26.15%)
$31.21 (-26.15%)
ASTH has High risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Low volume

ASTH overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
ASTH Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ASTH Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is ASTH current stock price?
What are ASTH stock strengths?
What is ASTH Risk Level?
What is ASTH market cap and volume?
What is ASTH current Stock IQ?
Should I buy ASTH stock right now?
Is ASTH a Strong Buy right now?
What does a 'Strong Buy' rating mean for ASTH?
What does a 'Strong Sell' rating mean for ASTH?
What factors influence ASTH's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+5.83%
+2.36%
-13.03%
-17.75%
+2.35%
ASTH
Astrana Health Inc.
Current Price
$23.05
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Chart
$31.21 (-26.15%)
$30.82 (-25.21%)
$31.21 (-26.15%)
$31.21 (-26.15%)
ASTH Analysts Opinion
ASTH Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
ASTH Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ASTH Street Sentiment is bullish and have positive views on the near-term outlook
ASTH has High risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Low volume

Average key support and resistance price levels.
ASTH Latest Analysis
Jefferies Maintains Astrana Health (ASTH) Buy Recommendation. Fintel reports that on November 25 2025 Jefferies maintained coverage of Astrana Health (NasdaqCM:ASTH) with a Buy recommendation. Analyst Price Forecast Suggests 91.25% Upside
Today
Barclays Maintains Astrana Health (ASTH) Equal-Weight Recommendation. Fintel reports that on November 24 2025 Barclays maintained coverage of Astrana Health (NasdaqCM:ASTH) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 92.10% Upside
Tue Nov 25, 2025
TD Cowen Maintains Astrana Health (ASTH) Buy Recommendation. Fintel reports that on November 10 2025 TD Cowen maintained coverage of Astrana Health (NasdaqCM:ASTH) with a Buy recommendation. Analyst Price Forecast Suggests 104.64% Upside
Tue Nov 11, 2025
RSI Alert: Astrana Health (ASTH) Now Oversold. Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me
Mon Nov 10, 2025
ASTH Makes Notable Cross Below Critical Moving Average. In trading on Friday shares of Astrana Health Inc (Symbol: ASTH) crossed below their 200 day moving average of $29.52 changing hands as low as $26.54 per share. Astrana Health Inc shares are currently trading down about 17.8% on the day. The chart below shows the one year pe
Fri Nov 7, 2025
Astrana Health Inc. (ASTH) Misses Q3 Earnings Estimates. Astrana Health Inc. (ASTH) delivered earnings and revenue surprises of -97.87% and 0.61% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Thu Nov 6, 2025
Astrana Health GAAP EPS of $0.01 misses by $0.43 revenue of $956M beats by $3.17M.
Thu Nov 6, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ASTH Stock trends
ASTH Stock performance
ASTH Stock analysis
ASTH investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.